Author

Eugenio Montini

The San Raffaele Telethon Institute for Gene TherapyORCID 0000-0003-1771-6067Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Developmental Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:clustering· 1 Assay:CRISPR screen· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Ivan MerelliiD· 2 shared Monica VolpiniD· 2 shared Adrian James ThrasheriD· 1 shared Alessandro SessaiD· 1 shared Alessia CavazzaiD· 1 shared Antonio CarusilloiD· 1 shared Asma NaseemiD· 1 shared Beatrice Martini· 1 shared

Activity by Year

2022-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Ivan MerelliORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Molecular BiologyMolecular Therapy AdvancesPeer-reviewedJul 22, 2026

In-Depth Characterization of Stem Cell Potency and Genotoxicity for Clinical-Scale Ex Vivo CRISPR/Cas9 Gene Editing

Asma Naseem, Winston Vetharoy, Thomas E. Whittaker…·Alessia Cavazza

This study develops a clinical-compliant framework for ex vivo CRISPR/Cas9 gene editing of HSPCs to correct WAS, showing improved engraftment and a favorable safety profile with minimal off-target effects.

1 citation

humanCRISPR screen

𝕏 PostBluesky

Cell BiologyMolecular TherapyPeer-reviewedMay 26, 2026

Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells from Human Mobilized Peripheral Blood for Gene Therapy Applications

Erika Zonari, Matteo Maria Naldini, Matteo Barcella…·Bernhard Gentner

This study optimizes an ex vivo expansion protocol for mobilized peripheral blood HSCs, enabling robust gene therapy applications with long-term engraftment.

1 citation

humanscRNA-seq

𝕏 PostBluesky

Developmental BiologybioRxivPreprintSep 12, 2022

Balanced SET levels favor the correct enhancer repertoire during cell fate acquisition

Mattia Zaghi, Federica Banfi, Luca Massimino…·Alessandro Sessa

The paper shows that SET levels influence enhancer usage during cell fate acquisition, leading to altered gene regulation and contributing to disease.

DOI 10.1101/2022.09.12.507599

humanChIP-seq

𝕏 PostBluesky